+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endoscopic Retrograde Cholangiopancreatography Market Size, Share & Trends Analysis Report By Product (Endoscopes, Endotherapy Devices), By Procedure (Biliary Sphincterotomy, Biliary Stenting), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 5990694
The global endoscopic retrograde cholangiopancreatography market size was estimated at USD 2.17 billion in 2024 and is projected to grow at a CAGR of 8.26% from 2025 to 2030. The market is gaining popularity due to its reduced risk of complications and faster recovery compared to traditional surgery. The growing incidence of chronic gastrointestinal and biliary conditions, including Crohn's disease, Barrett's esophagus, and liver disorders, is contributing to the growth.

This growth is majorly driven by the rising incidence of pancreatic and biliary diseases, such as gallstones, pancreatitis, and bile duct obstructions, which are fueling the demand for ERCP procedures. As the population ages and lifestyles change, the prevalence of these conditions is expected to increase, driving market growth. For instance, according to the National Health Service (NHS), more than one in ten adults in the UK has gallstones. Moreover, several studies indicated that the incidence rate of gallstones is anticipated to rise rapidly over the forecast period, driving the demand for ERCP procedures.

Furthermore, advances in endoscopic technology have improved the safety and efficacy of ERCP procedures. For instance, in January 2023, Advantech introduced the MIO-5377R single-board computer as a groundbreaking innovation in the field of endoscope technology. This compact and powerful device is designed to address the traditional challenges faced by endoscopes, offering enhanced performance, reliability, and functionality. Moreover, innovations such as high-definition imaging, better maneuverability of endoscopes, and the development of therapeutic accessories have made ERCP a more precise and effective diagnostic and treatment tool. These technological advancements are attracting both healthcare providers and patients to opt for ERCP procedures.

The rise in the adoption of minimally invasive surgical techniques has led to an increased demand for ERCP procedures, which is expected to drive growth in the industry in the upcoming years. For instance, according to the American Cancer Society's annual report published in January 2024, an estimated 41,630 new cases of liver cancer are expected to be diagnosed in the U.S. In addition, as per the same source, liver cancer is more prevalent in countries in sub- Southeast Asia and Saharan Africa compared to the U.S. It is the most common type of cancer in many of these nations, with over 800,000 new cases diagnosed globally each year. Moreover, liver cancer ranks as a leading cause of cancer-related deaths worldwide, claiming more than 700,000 lives annually.

Moreover, the increased awareness about the benefits of early diagnosis and treatment of pancreatic and biliary diseases has led to a higher demand for minimally invasive procedures such as ERCP. For instance, in October 2023, the Biliary Atresia Awareness Committee launched the Biliary Atresia Awareness Campaign under the guidance of the Gauteng Provincial Solid Organ Transplant Division and the University of the Witwatersrand at Charlotte Maxeke Academic Hospital. The campaign was aimed to raise awareness and support for children affected by biliary atresia. This rare and life-threatening liver disease affects infants by obstructing or obliterating bile ducts. The initiative was focused on educating diverse demographics about biliary atresia, offering resources and support to affected families, advancing research for diagnostic tools and treatments, and fostering collaboration with medical entities globally.

Global Endoscopic Retrograde Cholangiopancreatography Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global endoscopic retrograde cholangiopancreatography market report based on product, procedure, end use, and region.

Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Endoscopes
  • Endotherapy Devices
  • Sphincterotomes
  • Lithotripter
  • Stents
  • Cannulas
  • Forceps
  • Snares
  • Catheters
  • Guiding Wires
  • Balloons
  • Baskets
  • Visualization Systems
  • Energy Devices
  • Others

Procedure Outlook (Revenue, USD Million, 2018 - 2030)

  • Biliary Sphincterotomy
  • Biliary Stenting
  • Biliary Dilatation
  • Pancreatic Sphincterotomy
  • Pancreatic Duct Stenting
  • Pancreatic Duct Dilation

End use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals
  • Outpatient Facilities

Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Sweden
  • Denmark
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Procedure outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Endoscopic Retrograde Cholangiopancreatography Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Endoscopic Retrograde Cholangiopancreatography: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
Chapter 4. Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis, By Product, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Global Endoscopic Retrograde Cholangiopancreatography Market, by Product, 2018 to 2030
4.5. Endoscopes
4.5.1. Endoscopes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Endotherapy Devices
4.6.1. Endotherapy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.2. Sphincterotomes
4.6.2.1. Sphincterotomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.3. Lithotripter
4.6.3.1. Lithotripter Market Revenue Estimates and Fo recasts, 2018 - 2030 (USD Million)
4.6.4. Stents
4.6.4.1. Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.5. Cannulas
4.6.5.1. Cannulas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.6. Forceps
4.6.6.1. Forceps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.7. Snares
4.6.7.1. Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.8. Catheters
4.6.8.1. Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.9. Guiding Wires
4.6.9.1. Guiding Wires Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.10. Balloons
4.6.10.1. Balloons Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6.11. Baskets
4.6.11.1. Baskets Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Visualization Systems
4.7.1. Visualization Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Energy Devices
4.8.1. Energy Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Others
4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis, By Procedure, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Procedure Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Global Endoscopic Retrograde Cholangiopancreatography Market, by Procedure, 2018 to 2030
5.5. Biliary Sphincterotomy
5.5.1. Biliary Sphincterotomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Biliary Stenting
5.6.1. Biliary Stenting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Biliary Dilatation
5.7.1. Biliary Dilatation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Pancreatic Sphincterotomy
5.8.1. Pancreatic Sphincterotomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Pancreatic Duct Stenting
5.9.1. Pancreatic Duct Stenting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Pancreatic Duct Dilation
5.10.1. Pancreatic Duct Dilation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
6.1. Definition and Scope
6.2. End Use Market Share Analysis, 2024 & 2030
6.3. Segment Dashboard
6.4. Global Endoscopic Retrograde Cholangiopancreatography Market, by End Use, 2018 to 2030
6.5. Hospitals
6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Outpatient Facilities
6.6.1. Outpatient Facilities market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Endoscopic Retrograde Cholangiopancreatography Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Regional Market Snapshot
7.4. Endoscopic Retrograde Cholangiopancreatography Market Share by Region, 2024 & 2030:
7.5. North America
7.5.1. North America endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.5.2. U.S.
7.5.2.1. U.S. endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.5.3. Canada
7.5.3.1. Canada endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Mexico endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.6. Europe
7.6.1. Europe endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.6.2. UK
7.6.2.1. UK endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.6.3. Germany
7.6.3.1. Germany endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.6.4. France
7.6.4.1. France endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.6.5. Italy
7.6.5.1. Italy endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.6.6. Spain
7.6.6.1. Spain endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.6.7. Norway
7.6.7.1. Norway endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.6.8. Sweden
7.6.8.1. Sweden endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.6.9. Denmark
7.6.9.1. Denmark endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.7.2. China
7.7.2.1. China endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.7.3. India
7.7.3.1. India endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.8.2. Argentina
7.8.2.1. Argentina endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait endoscopic retrograde cholangiopancreatography market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Company Profiles
8.3.1. American Well
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Olympus Corporation
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. CONMED Corporation
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Boston Scientific Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Medtronic PLC
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Telemed System, Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Ambu A/S
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. FUJIFILM Holdings Corporation
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Hobbs Medical, Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Cook Group
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Streis PLC
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. HOYA Group
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Karl Storz SE & Co. KG
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 4. Global endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 5. Global endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 6. North America endoscopic retrograde cholangiopancreatography market, by region, 2018 - 2030 (USD Million)
Table 7. North America endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 8. North America endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 9. North America endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 10. U.S. endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 11. U.S. endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 12. U.S. endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 13. Mexico endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 14. Mexico endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 15. Mexico endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million
Table 16. Canada endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 17. Canada endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 18. Canada endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 19. Europe endoscopic retrograde cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
Table 20. Europe endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 21. Europe endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 22. Europe endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 23. UK endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 24. UK endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 25. UK endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 26. Germany endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 27. Germany endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 28. Germany endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 29. France endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 30. France endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 31. France endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 32. Italy endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 33. Italy endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 34. Italy endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 35. Spain endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 36. Spain endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 37. Spain endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 38. Norway endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 39. Norway endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 40. Norway endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 41. Sweden endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 42. Sweden endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 43. Sweden endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 44. Denmark endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 45. Denmark endoscopic retrograde cholangiopancreatography market, by procedure ype, 2018 - 2030 (USD Million)
Table 46. Denmark endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 47. Asia Pacific endoscopic retrograde cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
Table 48. Asia Pacific endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 49. Asia Pacific endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 50. Asia Pacific endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 51. Japan endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 52. Japan endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 53. Japan endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 54. China endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 55. China endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 56. China endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 57. India endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 58. India endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 59. India endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 60. Australia endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 61. Australia endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 62. Australia endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 63. South Korea endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 64. South Korea endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 65. South Korea endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 66. Thailand endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 67. Thailand endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 68. Thailand endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 69. Latin America endoscopic retrograde cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
Table 70. Latin America endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 71. Latin America endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 72. Latin America endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 73. Brazil endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 74. Brazil endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 75. Brazil endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 76. Argentina endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 77. Argentina endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 78. Argentina endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 79. Middle East & Africa endoscopic retrograde cholangiopancreatography market, by country, 2018 - 2030 (USD Million)
Table 80. Middle East & Africa endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 81. Middle East & Africa endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 82. Middle East & Africa endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 83. South Africa endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 84. South Africa endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 85. South Africa endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 86. Saudi Arabia endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 87. Saudi Arabia endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 88. Saudi Arabia endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 89. UAE endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 90. UAE endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 91. UAE endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
Table 92. Kuwait endoscopic retrograde cholangiopancreatography market, by product, 2018 - 2030 (USD Million)
Table 93. Kuwait endoscopic retrograde cholangiopancreatography market, by procedure, 2018 - 2030 (USD Million)
Table 94. Kuwait endoscopic retrograde cholangiopancreatography market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Endoscopic retrograde cholangiopancreatography market: outlook
Fig. 9 Endoscopic retrograde cholangiopancreatography competitive insights
Fig. 10 Ancillary market outlook
Fig. 11 Endoscopic retrograde cholangiopancreatography market driver impact
Fig. 12 Endoscopic retrograde cholangiopancreatography market restraint impact
Fig. 13 Porter’s Analysis
Fig. 14 PESTLE Analysis
Fig. 15 Endoscopic retrograde cholangiopancreatography market: Product movement analysis
Fig. 16 Endoscopic retrograde cholangiopancreatography market: Component outlook and key takeaways
Fig. 17 Endoscopes market estimates and forecast, 2018 - 2030
Fig. 18 Endotherapy Devices market estimates and forecast, 2018 - 2030
Fig. 19 Sphincterotomes market estimates and forecast, 2018 - 2030
Fig. 20 Lithotripter market estimates and forecast, 2018 - 2030
Fig. 21 Stents market estimates and forecast, 2018 - 2030
Fig. 22 Cannulas market estimates and forecast, 2018 - 2030
Fig. 23 Forceps market estimates and forecast, 2018 - 2030
Fig. 24 Snares market estimates and forecast, 2018 - 2030
Fig. 25 Catheters market estimates and forecast, 2018 - 2030
Fig. 26 Guiding Wires market estimates and forecast, 2018 - 2030
Fig. 27 Balloons market estimates and forecast, 2018 - 2030
Fig. 28 Baskets market estimates and forecast, 2018 - 2030
Fig. 29 Visualization Systems market estimates and forecast, 2018 - 2030
Fig. 30 Energy Devices market estimates and forecast, 2018 - 2030
Fig. 31 Others market estimates and forecast, 2018 - 2030
Fig. 32 Endoscopic retrograde cholangiopancreatography market: Procedure movement analysis
Fig. 33 Endoscopic retrograde cholangiopancreatography market: Procedure outlook and key takeaways
Fig. 34 Biliary Sphincterotomy market estimates and forecasts, 2018 - 2030
Fig. 35 Biliary Stenting market estimates and forecasts,2018 - 2030
Fig. 36 Biliary Dilatation market estimates and forecast, 2018 - 2030
Fig. 37 Pancreatic Sphincterotomy market estimates and forecast, 2018 - 2030
Fig. 38 Pancreatic Duct Stenting market estimates and forecast, 2018 - 2030
Fig. 39 Pancreatic Duct Dilation market estimates and forecast, 2018 - 2030
Fig. 40 Endoscopic retrograde cholangiopancreatography market: End Use movement analysis
Fig. 41 Endoscopic retrograde cholangiopancreatography market: End Use outlook and key takeaways
Fig. 42 Hospitals Therapy market estimates and forecasts, 2018 - 2030
Fig. 43 Outpatient Facilities market estimates and forecasts, 2018 - 2030
Fig. 44 Global endoscopic retrograde cholangiopancreatography market: Regional movement analysis
Fig. 45 Global endoscopic retrograde cholangiopancreatography market: Regional outlook and key takeaways
Fig. 46 North America endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Key country dynamics
Fig. 48 U.S. endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Key country dynamics
Fig. 50 Canada endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Key country dynamics
Fig. 52 Mexico endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Europe endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Key country dynamics
Fig. 55 UK endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Key country dynamics
Fig. 57 Germany endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Key country dynamics
Fig. 59 Spain endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Key country dynamics
Fig. 61 France endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Key country dynamics
Fig. 63 Italy endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 Key country dynamics
Fig. 65 Norway endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 66 Key country dynamics
Fig. 67 Denmark endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 68 Key country dynamics
Fig. 69 Sweden endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 70 Asia Pacific endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Key country dynamics
Fig. 72 Japan endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 73 Key country dynamics
Fig. 74 China endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 75 Key country dynamics
Fig. 76 India endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 77 Key country dynamics
Fig. 78 Australia endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Key country dynamics
Fig. 80 South Korea endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Thailand endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Latin America endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Brazil endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Argentina endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 MEA endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 South Africa endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 Saudi Arabia endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 UAE endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Kuwait endoscopic retrograde cholangiopancreatography market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Key company categorization
Fig. 98 Heat map analysis 2024

Companies Mentioned

  • Olympus Corporation
  • CONMED Corporation
  • Boston Scientific Corporation
  • Medtronic PLC
  • Telemed System, Inc.
  • AMBU, Inc.
  • FUJIFILM Holdings Corporation
  • Hobbs Medical, Inc.
  • Cook Group
  • Streis PLC
  • HOYA Group
  • Karl Storz SE & Co. KG

Methodology

Loading
LOADING...

Table Information